FR2940655B1 - Peptides isoles de facteur vii de lapin. - Google Patents

Peptides isoles de facteur vii de lapin.

Info

Publication number
FR2940655B1
FR2940655B1 FR0807517A FR0807517A FR2940655B1 FR 2940655 B1 FR2940655 B1 FR 2940655B1 FR 0807517 A FR0807517 A FR 0807517A FR 0807517 A FR0807517 A FR 0807517A FR 2940655 B1 FR2940655 B1 FR 2940655B1
Authority
FR
France
Prior art keywords
factor vii
isolated peptides
rabbit factor
rabbit
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0807517A
Other languages
English (en)
Other versions
FR2940655A1 (fr
Inventor
Julien Gras
Annick Sauger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LFB Biotechnologies SAS
Original Assignee
LFB Biotechnologies SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0807517A priority Critical patent/FR2940655B1/fr
Application filed by LFB Biotechnologies SAS filed Critical LFB Biotechnologies SAS
Priority to CN2009801535896A priority patent/CN102272606A/zh
Priority to KR1020117014806A priority patent/KR20110119622A/ko
Priority to AU2009334324A priority patent/AU2009334324A1/en
Priority to PCT/IB2009/056003 priority patent/WO2010076768A1/fr
Priority to EP09799188A priority patent/EP2384441A1/fr
Priority to US13/139,400 priority patent/US20110250702A1/en
Priority to JP2011544109A priority patent/JP2012514028A/ja
Priority to BRPI0917765A priority patent/BRPI0917765A2/pt
Priority to CA2748586A priority patent/CA2748586A1/fr
Publication of FR2940655A1 publication Critical patent/FR2940655A1/fr
Application granted granted Critical
Publication of FR2940655B1 publication Critical patent/FR2940655B1/fr
Priority to IL213454A priority patent/IL213454A0/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6437Coagulation factor VIIa (3.4.21.21)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21021Coagulation factor VIIa (3.4.21.21)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433Serine endopeptidases (3.4.21)
    • G01N2333/96441Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96447Factor VII (3.4.21.21)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR0807517A 2008-12-31 2008-12-31 Peptides isoles de facteur vii de lapin. Expired - Fee Related FR2940655B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR0807517A FR2940655B1 (fr) 2008-12-31 2008-12-31 Peptides isoles de facteur vii de lapin.
BRPI0917765A BRPI0917765A2 (pt) 2008-12-31 2009-12-31 peptédeos isolados do fator vii do coelho
AU2009334324A AU2009334324A1 (en) 2008-12-31 2009-12-31 Isolated peptides of rabbit factor VII
PCT/IB2009/056003 WO2010076768A1 (fr) 2008-12-31 2009-12-31 Peptides isoles de facteur vii de lapin
EP09799188A EP2384441A1 (fr) 2008-12-31 2009-12-31 Peptides isoles de facteur vii de lapin
US13/139,400 US20110250702A1 (en) 2008-12-31 2009-12-31 Isolated peptides of rabbit factor vii
CN2009801535896A CN102272606A (zh) 2008-12-31 2009-12-31 兔因子ⅶ的分离肽
KR1020117014806A KR20110119622A (ko) 2008-12-31 2009-12-31 토끼 인자 ⅶ의 분리된 펩티드
CA2748586A CA2748586A1 (fr) 2008-12-31 2009-12-31 Peptides isoles de facteur vii de lapin
JP2011544109A JP2012514028A (ja) 2008-12-31 2009-12-31 ウサギ第vii因子の単離されたペプチド
IL213454A IL213454A0 (en) 2008-12-31 2011-06-09 Isolated peptides of rabbit factor v11

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0807517A FR2940655B1 (fr) 2008-12-31 2008-12-31 Peptides isoles de facteur vii de lapin.

Publications (2)

Publication Number Publication Date
FR2940655A1 FR2940655A1 (fr) 2010-07-02
FR2940655B1 true FR2940655B1 (fr) 2011-02-18

Family

ID=40831299

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0807517A Expired - Fee Related FR2940655B1 (fr) 2008-12-31 2008-12-31 Peptides isoles de facteur vii de lapin.

Country Status (11)

Country Link
US (1) US20110250702A1 (fr)
EP (1) EP2384441A1 (fr)
JP (1) JP2012514028A (fr)
KR (1) KR20110119622A (fr)
CN (1) CN102272606A (fr)
AU (1) AU2009334324A1 (fr)
BR (1) BRPI0917765A2 (fr)
CA (1) CA2748586A1 (fr)
FR (1) FR2940655B1 (fr)
IL (1) IL213454A0 (fr)
WO (1) WO2010076768A1 (fr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE141646T1 (de) 1986-04-09 1996-09-15 Genzyme Corp Genetisch transformierte tiere, die ein gewünschtes protein in milch absondern
DE4007902A1 (de) * 1990-03-13 1991-09-19 Behringwerke Ag Synthetische peptide, die sequenzen aus faktor viia enthalten und deren verwendung
FR2677652B1 (fr) 1991-06-12 2005-05-27 Agronomique Inst Nat Rech Procede de preparation d'une proteine d'interet dans le lait d'un animal transgenique, produit obtenu et cellule eucaryote utilisee.
NZ330484A (en) 1994-02-16 1999-11-29 Pharming Bv Isolation of lactoferrin especially recombinant lactoferrin from milk
US5880327A (en) 1994-09-21 1999-03-09 American National Red Cross Transgenic mammals expressing human coagulation factor VIII
CA2371941A1 (fr) 1999-04-14 2000-10-19 Genzyme Transgenics Corporation Purification de proteines heterologues

Also Published As

Publication number Publication date
IL213454A0 (en) 2011-07-31
CN102272606A (zh) 2011-12-07
BRPI0917765A2 (pt) 2018-02-06
FR2940655A1 (fr) 2010-07-02
WO2010076768A1 (fr) 2010-07-08
JP2012514028A (ja) 2012-06-21
KR20110119622A (ko) 2011-11-02
US20110250702A1 (en) 2011-10-13
AU2009334324A1 (en) 2010-07-08
EP2384441A1 (fr) 2011-11-09
CA2748586A1 (fr) 2010-07-08

Similar Documents

Publication Publication Date Title
CY2019020I2 (el) Πρωτεϊνες προσδεσης καλλικρεϊνης πλασματος
BRPI0923359A2 (pt) Anticorpos anti-igf
BRPI0906877A2 (pt) Anticorpos anti-trkb aperfeiçoados
SMT201700083B (it) Anticorpi monoclonali
BRPI1011005A2 (pt) anticorpos anti-epcam
BRPI0819165A2 (pt) Anticorpos anti-vegf
DK2131860T3 (da) Anti-sclerostin-antistoffer
DK2059533T3 (da) Multispecifikke antistoffer
DK2443154T3 (da) Bispecifikke antigenbindingsproteiner
BR112012002226A2 (pt) anticorpos muc1.
BRPI1011965A2 (pt) estrutura de entressola.
DK3118220T3 (da) Protein
DK2265794T3 (da) Bælgventil
BRPI0814971A2 (pt) Proteína
BR112012000281A2 (pt) proteína quimérica.
DE102008045857B8 (de) Membranventil
BRPI0909633A2 (pt) anticorpos anti-tyrp1
DK2152108T3 (da) Fodtøjsemne
BRPI0915233A2 (pt) odorante frutado
BRPI1010661A2 (pt) peptídeo
DK2307543T3 (da) Forbedret proteinekspressionssystem
DK2103820T3 (da) Fikseringsenhed
BRPI0912769A2 (pt) anticorpos anti-pirb
BRPI0815733A2 (pt) Estrutura flutuante.
IT1394801B1 (it) Struttura di lampada.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140829